The authors also demonstrated that miR-199a-5p mediates Sirt1 expression and thus identified it as a potential target for AAA gene therapies, along with miR-34, miR-455-3p, and miR-125b-5p which are also upregulated in AAA patients. Here, SIRT1 is linked to triple-A syndrome.